We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Spire Healthcare Group Plc | LSE:SPI | London | Ordinary Share | GB00BNLPYF73 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
2.50 | 1.02% | 248.00 | 247.50 | 248.00 | 248.00 | 247.00 | 247.00 | 225,483 | 16:29:33 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Health & Allied Services,nec | 1.36B | 27.3M | 0.0676 | 36.69 | 1B |
Date | Subject | Author | Discuss |
---|---|---|---|
07/11/2018 15:21 | 1% interim not bad and better than most bank accounts. Of course the huge crash in share price has been disgraceful here for shareholders. | justiceforthemany | |
07/11/2018 13:40 | don't spend it all at once ;-) | bountyhunter | |
07/11/2018 13:10 | Reminder - this goes ex-dividend next week. 1.3p/share | justiceforthemany | |
07/11/2018 09:46 | It looks like the results will beat expectations to me, hence the recent director buying. Once the price has stabilised as it has looked to have done,that is when a smart bidder is likely to move in I expect. The bottom looks to be in with that buying of shares by a director. Any rally is likely to spur bid speculation I would expect. | value king | |
07/11/2018 08:05 | Lets hope there is a deal somewhere along the line. However, the recent insider share purchase implies that there are currently no such talks at the board level... | fahads | |
06/11/2018 17:22 | Looking increasingly like Mediclinic will make another bid in the coming days and try and close this saga once and for all. Selling their entire stake would be madness wasting years and crystallising a huge £300M+ loss. | justiceforthemany | |
05/11/2018 16:38 | Directors now well placed to accept a lower offer having averaged down. More director buys should follow. | justiceforthemany | |
05/11/2018 14:42 | Director purchase just notified of 200,000 ordinary shares at 132.08p, must be confident as that's a fair amount for a NED who is in no way obligated to buy. | bountyhunter | |
02/11/2018 12:21 | Healthcare sector doing better this week. Mediclinic up 5% today. | justiceforthemany | |
02/11/2018 09:31 | Weekend papers could be very interesting here. | justiceforthemany | |
02/11/2018 06:48 | The FCA should investigate the reasons behind the recent massive ~70% drop here imo. | bountyhunter | |
01/11/2018 22:45 | Connor, Clark & Lunn - are you just gamblers or do you have an inside source and feed to the Spire and Mediclinic boards? | justiceforthemany | |
01/11/2018 19:25 | with a bit of luck the ridiculously low price that this has fallen to will result in a bidding war | bountyhunter | |
01/11/2018 17:57 | “With Spire now trading below its freehold property value, we view it increasingly likely that Mediclinic will make another attempt to acquire the company.” INVESTEC 8th October At the time Spire was trading at 132p - before its plunge to 103p. An outrage. MDC, NMC and HCA are all likely bidders IMO. | justiceforthemany | |
01/11/2018 17:52 | Marshall Wace made the right call in reducing their short didn't they? Wonder if they got a tip off about the FT Betaville article? I think we all know the answer don't we? We may yet remain in the FTSE350 come December. | justiceforthemany | |
01/11/2018 17:48 | about time... Spire Healthcare Shares Rise 12% After Bid Speculation A hedge fund owned by Advent International took a 2.6% stake in Spire By Philip Waller November 1, 2018 4:03 p.m. GMT "Shares in Spire Healthcare PLC have risen 12% to 132 pence amid market speculation that the private-hospital operator could face a private-equity takeover. Reports highlighted the fact that a hedge fund owned by Advent International had taken a 2.6% stake in Spire. A source close to Advent told Dow Jones Newswires that the fund's strategy differs from that of Advent and that the private-equity firm is not pursuing a bid for Spire. Still, Investec PLC analysts said last month that they believed Spire's rival Mediclinic International PLC is likely to bid again for the company after having a £1.2 billion approach rejected in November last year..." | bountyhunter | |
01/11/2018 17:40 | ADVFN Buy/Sell volumes for today are pretty closely matched... ...could that late trade of just a single share reported at 17:33 be some kind of a signal I wonder | bountyhunter | |
01/11/2018 17:30 | 12.4% rise on the day & on high volume for a change. Offer must be imminent - either tomorrow or more likely Monday IMO. | justiceforthemany | |
01/11/2018 16:13 | Very good results from Smith and Nephew, the surgical prosthesis makers. Whatever happens ref. Brexit and other uncertainties, British private medical care is absolutely world-class. Pharma/medical tends to be defensive too, so hope for some protection if markets swoon from here. The recent share price performance reminds me of Horizon Diagnostics (HZD), which is a superb UK bio-genetics company. For no apparent reason some while ago, its share price slumped to a low of £1.06. Thence a recovery to c.£2,40 odd, and now steady at c.£2.00. Whilst deeply disconcerting for long-holders, these crazy share price slumps can be huge opportunities if there's a bit of cash on the side to scoop up the low levels. Good luck everybody ! | enteleon | |
01/11/2018 13:42 | off course it doesn't, I'm well aware of the ridiculous level of the recent sell-off; fear and greed drive the stock market, having been greedy now the shorters are fearful that they are going to get badly burnt if they don't close in time! | bountyhunter | |
01/11/2018 12:17 | A rise of 10% hardly makes up for a 70% decline since the offer. Yes SEVENTY PERCENT!!! | justiceforthemany | |
01/11/2018 11:55 | no way would I sell out at these levels! ...a long way back up to go yet imho ;-) | bountyhunter |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions